New Delhi: Insulin is the key hormone responsible for management of type-1 and type-2 diabetes. This helps millions of people live longer and relatively healthier lives while dealing with a chronic condition that causes blood sugar spikes. To combat this, scientists have now developed a new, smart insulin that responds to blood sugar spikes in real time. Known as ‘holy grail’, this form of insulin mimics body changes to blood sugar spikes reducing the number of times the body has to struggle with it.
How does the holy grail work to manage diabetes?
Unlike type-2 diabetes, not much can be done to prevent oneself from developing type-1 diabetes. Often diagnosed in children, this condition damages insulin-producing cells in the pancreas which controls blood sugar levels. Patients suffering from this condition must inject themselves with synthetic insulin 10 times a day to live. Such constant fluctuations between high and low blood sugar damage the heart and vision. Experts say that standard insulins in pharmacies stabilise blood sugar after entering the body. However, once done, it cannot work to stabilise sugar anymore. Which is why patients need to inject it frequently.
Holy Grail, on the other hand, needs to be taken only once a week. This could also be the best, closest solution to type-1 diabetes as compared to any drug therapy. Researchers at Stanford University in the US, Monash University in Australia, and Zhejiang University in China were part of the research projects that aimed at developing smart insulin.
Researchers said that four projects have been in the process of creating smart insulins. However, another has been launched to find an extremely fast-acting variant. Researchers say that the new GRIs could be the ‘holy grail’ of insulin. The innovation could go a long way in helping diabetics manage their condition daily thereby balancing glycemic control while avoiding high blood sugar. Experts also said that the new solution could help reduce negative effects in the long run and even preserve the physical and mental health of patients managing the condition.
Unlike type-2 diabetes, not much can be done to prevent oneself from developing type-1 diabetes. Often diagnosed in children, this condition damages insulin-producing cells in the pancreas which controls blood sugar levels. Patients suffering from this condition must inject themselves with synthetic insulin 10 times a day to live. Health News Health News: Latest News from Health Care, Mental Health, Weight Loss, Disease, Nutrition, Healthcare
